{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T22:26:34Z","timestamp":1774304794189,"version":"3.50.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Ovariostasis is a reversible and temporary suspension of the cyclic ovarian activity, characterized by anovulation and hypogonadotropinemia (low serum concentrations of FSH and LH), which can be observed in case of pregnancy or hypothalamic amenorrhea or medically obtained through the administration of combined hormonal contraceptives, progestin-only pills, or GnRH analogues. Ovariostasis effectively prevents undesired pregnancies, ovarian torsion, and hemorrhagic corpus luteum. Moreover, ovariostasis can be useful for the treatment of primary dysmenorrhea, polycystic ovary syndrome, endometriosis, adenomyosis, uterine fibroids, and abnormal uterine bleeding. Ovariostasis also offers long-term benefits; for example, a significant risk reduction for ovarian, colorectal, and endometrial cancer, despite a slightly increased breast cancer risk. According to limited data, ovariostasis may have an influence on the age of onset of natural menopause. Experimental studies on mice hypothesize positive effects of ovariostasis on the ovarian reserve, thereby contributing to preservation of fertility. Ovariostasis can be considered as a practical, effective tool to prevent and treat gynecological pathologies in women of reproductive age and needs further studies on humans to evaluate its influence on the reproductive lifespan and ovarian reserve.<\/jats:p>","DOI":"10.1093\/humrep\/deaf063","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T18:38:26Z","timestamp":1743273506000},"page":"983-988","source":"Crossref","is-referenced-by-count":4,"title":["\u2018Ovariostasis\u2019 as the main preventive and therapeutic strategy for gynecological pathologies in women of reproductive age"],"prefix":"10.1093","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7921-9547","authenticated-orcid":false,"given":"Antonio","family":"La Marca","sequence":"first","affiliation":[{"name":"Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia , Modena,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7894-1148","authenticated-orcid":false,"given":"Chiara","family":"Selmi","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia , Modena,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"2025060201511673500_deaf063-B1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/13625187.2018.1435779","article-title":"Effects of combined oral contraceptives on the clinical and biochemical parameters of hyperandrogenism in patients with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"23","author":"Amiri","year":"2018","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"2025060201511673500_deaf063-B2","first-page":"721","article-title":"Clinical risk factors for ovarian torsion","volume":"35","author":"Asfour","year":"2015","journal-title":"J Obstet Gynaecol"},{"key":"2025060201511673500_deaf063-B3","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.3390\/cancers13225654","article-title":"Oral contraceptive use and breast cancer risk assessment: a systematic review and meta-analysis of case-control studies, 2009-2020","volume":"13","author":"Bara\u0144ska","year":"2021","journal-title":"Cancers"},{"key":"2025060201511673500_deaf063-B4","doi-asserted-by":"crossref","first-page":"hoac009","DOI":"10.1093\/hropen\/hoac009","article-title":"ESHRE guideline: endometriosis","volume":"2022","author":"Becker","year":"2022","journal-title":"Hum Reprod Open"},{"key":"2025060201511673500_deaf063-B5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/humupd\/dmp017","article-title":"Oral contraceptives and colorectal cancer risk: a systematic review and meta-analysis","volume":"15","author":"Bosetti","year":"2009","journal-title":"Hum Reprod Update"},{"key":"2025060201511673500_deaf063-B6","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.bpobgyn.2009.02.001","article-title":"Diagnosis and management of ovarian cyst accidents","volume":"23","author":"Bottomley","year":"2009","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2025060201511673500_deaf063-B7","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1016\/j.cub.2021.06.076","article-title":"Ovulation suppression protects against chromosomal abnormalities in mouse eggs at advanced maternal age","volume":"31","author":"Chatzidaki","year":"2021","journal-title":"Curr Biol"},{"key":"2025060201511673500_deaf063-B8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls","volume":"371","author":"Collaborative Group on Epidemiological Studies of Ovarian Cancer","year":"2008","journal-title":"Lancet"},{"key":"2025060201511673500_deaf063-B9","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ajog.2020.06.004","article-title":"Menstruation: science and society","volume":"223","author":"Critchley","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"2025060201511673500_deaf063-B10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jogc.2023.04.008","article-title":"Guideline No. 437: diagnosis and management of adenomyosis","volume":"45","author":"Dason","year":"2023","journal-title":"J Obstet Gynaecol Can"},{"key":"2025060201511673500_deaf063-B11","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/bcp.15897","article-title":"Considerations on implementation of the newest treatment for symptomatic uterine fibroids: oral GnRH antagonists","volume":"90","author":"de Lange","year":"2024","journal-title":"Br J Clin Pharmacol"},{"key":"2025060201511673500_deaf063-B12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.critrevonc.2019.03.001","article-title":"Breast cancer risk of hormonal contraception: counselling considering new evidence","volume":"137","author":"Del Pup","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"key":"2025060201511673500_deaf063-B13","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/17512433.2020.1783247","article-title":"G. Drospirenone 4 mg-only pill (DOP) in 24\u2009+\u20094 regimen: a new option for oral contraception","volume":"13","author":"Savio","year":"2020","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2025060201511673500_deaf063-B14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1472-6483(10)60444-0","article-title":"Human corpus luteum physiology and the luteal-phase dysfunction associated with ovarian stimulation","volume":"18","author":"Devoto","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"2025060201511673500_deaf063-B15","doi-asserted-by":"crossref","first-page":"1428597","DOI":"10.3389\/fendo.2024.1428597","article-title":"Are natural estrogens used in contraception at lower risk of venous thromboembolism than synthetic ones? A systematic literature review and meta-analysis","volume":"15","author":"Douxfils","year":"2024","journal-title":"Front Endocrinol"},{"key":"2025060201511673500_deaf063-B16","doi-asserted-by":"crossref","first-page":"107944","DOI":"10.1016\/j.maturitas.2024.107944","article-title":"Perimenopausal abnormal uterine bleeding","volume":"184","author":"Dreisler","year":"2024","journal-title":"Maturitas"},{"key":"2025060201511673500_deaf063-B17","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/humupd\/dmu030","article-title":"Simultaneous prevention of unintended pregnancy and STIs: a challenging compromise","volume":"20","author":"Workshop Group","year":"2014","journal-title":"Hum Reprod Update"},{"key":"2025060201511673500_deaf063-B18","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1158\/1055-9965.EPI-13-0298","article-title":"Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review","volume":"22","author":"Gierisch","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2025060201511673500_deaf063-B19","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1177\/2047487318774847","article-title":"Association between progestin-only contraceptive use and cardiometabolic outcomes: a systematic review and meta-analysis","volume":"25","author":"Glisic","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"2025060201511673500_deaf063-B20","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1210\/jc.2017-00131","article-title":"Functional hypothalamic amenorrhea: an endocrine society clinical practice guideline","volume":"102","author":"Gordon","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2025060201511673500_deaf063-B21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/13625187.2024.2375285","article-title":"Inhibition ratio (I.R.) and transformation index (T.I.): new indexes to compare the effectiveness and clinical behaviour of modern progestin-only pills (POP)","volume":"29","author":"Grandi","year":"2024","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"2025060201511673500_deaf063-B22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2165\/00024677-200605060-00004","article-title":"A review of transdermal hormonal contraception\u202f: focus on the ethinylestradiol\/norelgestromin contraceptive patch","volume":"5","author":"Graziottin","year":"2006","journal-title":"Treat Endocrinol"},{"key":"2025060201511673500_deaf063-B23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.thromres.2004.06.038","article-title":"Growth and function of the normal human placenta","volume":"114","author":"Gude","year":"2004","journal-title":"Thromb Res"},{"key":"2025060201511673500_deaf063-B24","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1007\/s00198-019-05103-6","article-title":"Bone health in estrogen-free contraception","volume":"30","author":"Hadji","year":"2019","journal-title":"Osteoporos Int"},{"key":"2025060201511673500_deaf063-B25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2217\/17455057.5.1.91","article-title":"Corpus luteum hemorrhage in women with bleeding disorders","volume":"5","author":"Hoffman","year":"2009","journal-title":"Womens Health (Lond)"},{"key":"2025060201511673500_deaf063-B26","doi-asserted-by":"crossref","first-page":"e0303823","DOI":"10.1371\/journal.pone.0303823","article-title":"Combined oral contraceptive utilization and uterine fibroid incidence: a prospective study in a cohort of African-American women","volume":"19","author":"Hoffman","year":"2024","journal-title":"PLoS One"},{"key":"2025060201511673500_deaf063-B27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/ijgo.12238","article-title":"Effect of extended oral contraception use on the prevalence of fetal trisomy 21 in women aged at least 35 years","volume":"138","author":"Hor\u00e1nyi","year":"2017","journal-title":"Int J Gynaecol Obstet"},{"key":"2025060201511673500_deaf063-B28","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s12884-024-06587-9","article-title":"Assessing the impact of contraceptive use on mental health among women of reproductive age\u2014a systematic review","volume":"24","author":"Jahanfar","year":"2024","journal-title":"BMC Pregnancy Childbirth"},{"key":"2025060201511673500_deaf063-B29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bpobgyn.2018.01.007","article-title":"The significance and evolution of menstruation","volume":"50","author":"Jarrell","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2025060201511673500_deaf063-B30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.contraception.2010.07.008","article-title":"Vaginal ring contraception","volume":"83","author":"Kerns","year":"2011","journal-title":"Contraception"},{"key":"2025060201511673500_deaf063-B31","first-page":"CD009849","article-title":"Steroidal contraceptives and bone fractures in women: evidence from observational studies","volume":"2015","author":"Lopez","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2025060201511673500_deaf063-B32","doi-asserted-by":"crossref","first-page":"R263","DOI":"10.1677\/ERC-10-0076","article-title":"Hormonal contraception and risk of endometrial cancer: a systematic review","volume":"17","author":"Mueck","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"2025060201511673500_deaf063-B33","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.contraception.2012.08.040","article-title":"Lower risk for Down syndrome associated with longer oral contraceptive use: a case-control study of women of advanced maternal age presenting for prenatal diagnosis","volume":"87","author":"Nagy","year":"2013","journal-title":"Contraception"},{"key":"2025060201511673500_deaf063-B34","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.contraception.2012.04.009","article-title":"Hormonal contraception and bone metabolism: a systematic review","volume":"86","author":"Nappi","year":"2012","journal-title":"Contraception"},{"key":"2025060201511673500_deaf063-B35","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jogc.2022.10.012","article-title":"Efficacy and safety of oral GnRH antagonists in patients with uterine fibroids: a systematic review","volume":"44","author":"Niaz","year":"2022","journal-title":"J Obstet Gynaecol Can"},{"key":"2025060201511673500_deaf063-B36","doi-asserted-by":"crossref","first-page":"e2335957","DOI":"10.1001\/jamanetworkopen.2023.35957","article-title":"Mental health symptoms in oral contraceptive users during short-term hormone withdrawal","volume":"6","author":"Noachtar","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2025060201511673500_deaf063-B37","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3803\/EnM.2021.958","article-title":"An update on contraception in polycystic ovary syndrome","volume":"36","author":"Oguz","year":"2021","journal-title":"Endocrinol Metab (Seoul)"},{"key":"2025060201511673500_deaf063-B38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1472-6483(11)60210-1","article-title":"Gonadotrophin-releasing hormone (GnRH) and GnRH agonists: mechanisms of action","volume":"5","author":"Ortmann","year":"2002","journal-title":"Reprod Biomed Online"},{"key":"2025060201511673500_deaf063-B39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S1526-9523(03)00061-8","article-title":"Abnormal uterine bleeding in adolescents","volume":"48","author":"Quint","year":"2003","journal-title":"J Midwifery Womens Health"},{"key":"2025060201511673500_deaf063-B40","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0002-9378(99)70120-1","article-title":"The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices","volume":"181","author":"Rivera","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"2025060201511673500_deaf063-B41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.maturitas.2019.10.012","article-title":"Reproductive factors and age at natural menopause: a systematic review and meta-analysis","volume":"131","author":"Roman Lay","year":"2020","journal-title":"Maturitas"},{"key":"2025060201511673500_deaf063-B42","first-page":"33","article-title":"Adenomyosis: diagnosis and management","volume":"105","author":"Schrager","year":"2022","journal-title":"Am Fam Physician"},{"key":"2025060201511673500_deaf063-B43","first-page":"CD002120","article-title":"Combined oral contraceptive pill for primary dysmenorrhoea","volume":"7","author":"Schroll","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"2025060201511673500_deaf063-B44","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"189","author":"Teede","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"2025060201511673500_deaf063-B45","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.fertnstert.2018.01.013","article-title":"Role of medical therapy in the management of uterine adenomyosis","volume":"109","author":"Vannuccini","year":"2018","journal-title":"Fertil Steril"},{"key":"2025060201511673500_deaf063-B46","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.fertnstert.2024.04.041","article-title":"The modern management of uterine fibroids-related abnormal uterine bleeding","volume":"122","author":"Vannuccini","year":"2024","journal-title":"Fertil Steril"},{"key":"2025060201511673500_deaf063-B47","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/humrep\/dead206","article-title":"Proposal for targeted, neo-evolutionary-oriented secondary prevention of early-onset endometriosis and adenomyosis. Part II: medical interventions","volume":"39","author":"Vercellini","year":"2024","journal-title":"Hum Reprod"},{"key":"2025060201511673500_deaf063-B48","first-page":"dead229","article-title":"Proposal for targeted, neo-evolutionary-oriented, secondary prevention of early-onset endometriosis and adenomyosis. Part I: pathogenic aspects","volume":"39","author":"Vercellini","year":"2024","journal-title":"Hum Reprod"},{"key":"2025060201511673500_deaf063-B49","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.fertnstert.2016.10.022","article-title":"Estrogen-progestins and progestins for the management of endometriosis","volume":"106","author":"Vercellini","year":"2016","journal-title":"Fertil Steril"},{"key":"2025060201511673500_deaf063-B50","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/humupd\/dmq042","article-title":"Oral contraceptives and risk of endometriosis: a systematic review and meta-analysis","volume":"17","author":"Vercellini","year":"2011","journal-title":"Hum Reprod Update"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/40\/6\/983\/62857631\/deaf063.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/40\/6\/983\/62857631\/deaf063.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T05:51:30Z","timestamp":1748843490000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/40\/6\/983\/8105712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,4,3]]},"published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deaf063","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2025,4,3]]}}}